TGFRX Mutual Fund

TGFRX Mutual Fund

NAV$61.99
See how much of TGFRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of May 31, 2026

Net Assets
$35M
Expense Ratio
1.95%
Dividend Yield (Current)
-
Holdings
25
Inception Date
Dec 30, 1998
Fund Family
Tanaka Capital Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+10.23%
1 Year+18.31%
3 Year+28.76%
5 Year+13.19%
10 Year+15.37%

Asset Allocation

Stocks: 100.00%
See how much of TGFRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
CORTCorcept Therapeutics Inc9.14%
NVDANvidia Corp7.41%
UAMYUs Antimony Corp.7.34%
NUVBNuvation Bio Inc5.83%
NXE:CANexgen Energy Ltd5.54%
Top 10 Concentration: 58.49%Report Date: May 31, 2026
Download all 25 holdings for TGFRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$2.65
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

TGFRX Mutual Fund Overview

TGFRX Mutual Fund (TANAKA Growth Fund Class R) is managed by Tanaka Capital Management with $35.3M in net assets. TGFRX expense ratio is 1.95%, holding 25 positions across sectors including Information Technology, Health Care, Materials. Inception date: 1998-12-30.

TGFRX performance shows a YTD return of 10.23%. The 1-year return is 18.31% and the 5-year return is 13.19%.

TGFRX top holdings include Corcept Therapeutics Inc (9.1%), Nvidia Corp (7.4%), Us Antimony Corp. (7.3%), Nuvation Bio Inc (5.8%), Nexgen Energy Ltd (5.5%). Go to all TGFRX holdings, TGFRX sectors, or TGFRX dividends.

TGFRX can be compared against other funds. Use TGFRX overlap to find shared positions, or TGFRX vs another fund for a side-by-side view. TGFRX alternatives are available via the screener, along with tax-loss harvesting opportunities.